Launching portfolio

NCEs - Therapeutic category Generics* - Product

* Samples are available for countries with no patent issues. Otherwise, samples for R&D purposes are only available for those countries which have implemented a Bolar-like provision. Samples for R&D use in the United States are available as permitted under 35 U.S.C. § 271 (e) (1) .